The goal of this observational study is to evaluate the impact of different atrial pacing sites-Bachmann's bundle pacing versus right atrial appendage pacing-on the development and progression of atrial cardiomyopathy in patients diagnosed with sick sinus syndrome who are undergoing permanent pacemaker implantation.
Previous studies have reported that conventional Right Atrial Appendage pacing is associated with delayed atrial activation time. A higher burden of atrial pacing at this site has been linked to an increased incidence of atrial fibrillation and atrial tachycardia. Furthermore, structural and functional deterioration of the atria-specifically Left Atrial dilation and reduced left atrial strain-has been observed in patients with a high percentage of Right Atrial Appendage pacing. These changes are known to accelerate the progression of atrial cardiomyopathy, potentially leading to adverse long-term clinical outcomes. To address these limitations, Bachmann Bundle Pacing has emerged as a promising alternative pacing site. The Bachmann bundle is a major atrial myoarchitecture connecting the right and left atria. Pacing at this site is expected to facilitate interatrial conduction, thereby restoring interatrial synchrony and mitigating interatrial block. Prior research indicates that pacing at the Bachmann bundle is associated with a reduced incidence of atrial fibrillation and atrial tachycardia, suggesting distinct benefits regarding atrial electrophysiological outcomes. However, existing studies have primarily focused on electrophysiological parameters, such as arrhythmia incidence. Consequently, the impact of Bachmann Bundle Pacing on atrial structural and functional remodeling remains to be clearly elucidated. Therefore, this study is designed as a single-center cohort study enrolling a total of 200 subjects (100 prospective and 100 retrospective). We will analyze echocardiographic parameters over a 12-month period following pacemaker implantation. By comprehensively analyzing imaging parameters (left atrial/right atrial strain and volume changes assessed via echocardiography) and clinical outcomes (atrial arrhythmias, heart failure hospitalization, and mortality), this study aims to investigate the differential effects of Bachmann Bundle Pacing versus Right Atrial Appendage pacing on the development and progression of atrial cardiomyopathy.
Study Type
OBSERVATIONAL
Enrollment
200
Atrial lead positioned in the right atrial appendage
Atrial lead positioned in the bachmann bundle branch
Samsung Medical Center
Seoul, Seoul, South Korea
RECRUITINGStructural echocardiographic parameters of the left atrium
LA Volume Index measured as mL/m\^2
Time frame: 6 and 12 months after pacemaker implantation
Functional echocardiographic parameters of the left atrium
Reservoir Strain (%), Conduit Strain (%), Contraction Strain (%)
Time frame: 6 and 12 months after pacemaker implantation
Structural echocardiographic parameters of the left ventricle
LV End-Diastolic Diameter(mm), LV End-Systolic Diameter(mm)
Time frame: 6 and 12 months after pacemaker implantation
Functional echocardiographic parameters of the left ventricle
LV Ejection Fraction (%), Global Longitudinal Strain (%)
Time frame: 6 and 12 months after pacemaker implantation
Mitral and tricuspid regurgitation volume
as mL per beat
Time frame: 6 and 12 months after pacemaker implantation
Structural echocardiographic parameters of the right atrium
RA Volume Index (mL/m\^2)
Time frame: 6 and 12 months after pacemaker implantation
Functional echocardiographic parameters of the right atrium
RA Reservoir Strain (%), RA Conduit Strain (%), RA Contraction Strain (%)
Time frame: 6 and 12 months after pacemaker implantation
ECG parameters
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
PR interval (ms), QRS duration (ms), P wave duration (ms), QTC (ms)
Time frame: 6 and 12 months after pacemaker implantation
Average heart rate
bpm
Time frame: 6 and 12 months after pacemaker implantation
Heart rate distribution
percentage (%)
Time frame: 6 and 12 months after pacemaker implantation
Pacing burden
percentage (%)
Time frame: 6 and 12 months after pacemaker implantation
Atrial fibrillation burden
percentage (%)
Time frame: 6 and 12 months after pacemaker implantation
atrial fibrillation occurrence
count
Time frame: 6 and 12 months after pacemaker implantation
NTproBNP
pg/ml
Time frame: 6 and 12 months after pacemaker implantation
Procedure-related complications
count
Time frame: 6 and 12 months after pacemaker implantation
Pacemaker/Implantable cardioverter defibrillator parameters
Threshold (V)
Time frame: 6 and 12 months after pacemaker implantation
Pacemaker/Implantable cardioverter defibrillator parameters
longevity (year)
Time frame: 6 and 12 months after pacemaker implantation
Cardiac mortality
count
Time frame: 6 and 12 months after pacemaker implantation
All-cause mortality
count
Time frame: 6 and 12 months after pacemaker implantation
Patient's functional status
NYHA class I\~IV
Time frame: 6 and 12 months after pacemaker implantation
hospitalization due to heart failure
count
Time frame: 6 and 12 months post-procedure
re-admission due to any cause
count
Time frame: 6 and 12 months post-procedure
Cerebrovascular event
count
Time frame: 6 and 12 months post-procedure